Product information

Current status:

Approved

Current status date:

2021-01-18

Product name:

TERAZOSIN

DIN:

02233050 Electronic product monograph is not available

Company:

APOTEX INC
150 Signet Drive
Toronto
Ontario
Canada M9L 1T9

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

24:20.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

G04CA03 TERAZOSIN

Active ingredient group (AIG) number:^{See footnote5}

0136978004